Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 15 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck Cancer

    Rochester, MN

  2. Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

    Scottsdale/Phoenix, AZ

  3. Evaluating Highly Flexible (aka AIR) RF Coils for Patients Undergoing MR Imaging for Radiation Therapy Planning

    Rochester, MN

  4. Pre-operative Vs. Post-operative Radiosurgery For Metastatic Brain Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. Eliminating Breast Cancer Surgery In Exceptional Responders With Neoadjuvant Systemic Therapy

    Rochester, MN

  6. Testicular Tissue Cryopreservation In Children

    Rochester, MN

  7. A Study Of Intratumoral Injection Of Autologous Dendritic Cells After High-Dose Conformal External Beam Radiotherapy In Patients With Unresectable Liver Cancer

    Rochester, MN

  8. A Study Of Lutetium Lu 177 Dotatate (Lutathera®) In Patients With Inoperable, Progressive Meningioma After External Beam Radiation Therapy

    Rochester, MN

  9. EF-41/KEYNOTE D58: Phase 3 Study Of Optune Concomitant With Temozolomide Plus Pembrolizumab In Newly Diagnosed Glioblastoma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  10. A Study to Compare Optimal MRI Timing for Pre-surgical Planning to LINAC-based Therapy

    Rochester, MN

.

Mayo Clinic Footer